通过抑制NF-κB通路和增强亡,使PDAC对杰姆西塔素敏感
Enhui Jin1, Maria Rita Gil da Silva Simões1, Steve O'Hagan2
1Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
Pharmaceuticals (Basel, Switzerland)
|February 27, 2026
概括
一个新的分子,B12,通过减少化学抵抗,在胰腺癌模型中增强了gemcitabine的疗效. 这种药物敏感剂具有最小的毒性,为改善胰腺管道腺癌治疗结果提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 胰腺管道腺癌 (PDAC) 显示出由于化学抵抗而对凝心素的反应不佳.
- 对于增强gemcitabine疗效而不会增加毒性的药物有着至关重要的需求.
研究的目的:
- 描述一个小分子,B12,作为一个潜在的gemcitabine感应剂PDAC.
- 为了评估B12在PDAC细胞模型中克服耐 gemcitabine 的能力.
主要方法:
- 测量MTT测试以确定IC50和剂量修改因子 (DMF).
- 殖民地形成,伤口划伤,JC-1和Annexin V/PI测定用于表型和亡分析.
- 通过p65分离和RT-qPCR进行转录形状分析和NF-κB通路分析.
主要成果:
- 单独B12显示出最小的细胞毒性,但在PDAC细胞中降低了gemcitabine的IC50的1.39倍.
- 与B12和gemcitabine的同时治疗增强了亡,抑制了增殖,并减少了殖民地形成.
- 转录组分析揭示了参与生长和生存的B12下调基因,与减少NF-κB信号相关.
结论:
- 维生素B12有效地使PDAC细胞对gemcitabine具有低内在毒性的敏感性.
- 敏感化效应与亡的增加和抑制NF-κB信号传递有关.
- 需要进一步验证以确认因果关系和正常细胞缺乏敏感性.
更多相关视频
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
28.8K
06:21Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
12.3K
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
691
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
691
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K